FDA · 药品动态·· 1 天前精选AI 评分75
FDA拒绝Summit Therapeutics的肺癌药物ivonescimab
FDA rejects Summit Therapeutics’ ivonescimab lung cancer drug - Manufacturing Chemist
AI 导读
据Manufacturing Chemist报道,FDA拒绝了Summit Therapeutics的肺癌药物ivonescimab。该报道未披露完整正文,具体审评意见与药物适应症细节尚不明确。
来源:FDA · 药品动态 · news.google.com